| J9271 | Injection, pembrolizumab, 1 mg | 15,800 | $40 | $679.4K |
| J0897 | Injection, denosumab, 1 mg | 8,640 | $20 | $155.5K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 8,800 | $20 | $149.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,150 | $100 | $109.3K |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 2,900 | $30 | $75.5K |
| J3590 | Unclassified biologics | 20 | $3,630 | $61.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 610 | $100 | $58.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 200 | $120 | $24.4K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 150 | $140 | $20.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $60 | $19.6K |